Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

mi
from
Twin Cities, MN
Children's Hospitals and Clinics of Minnesota
mi
from
Twin Cities, MN
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Fort Smith, AR
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Santa Clara, CA
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Aurora, CO
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Washington,
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Park Ridge, IL
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Indianapolis, IN
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Metairie, LA
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Boston, MA
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Ann Arbor, MI
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Omaha, NE
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Newark, NJ
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
New York, NY
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Cleveland, OH
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated:  8/2/2013
mi
from
Philadelphia, PA
A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections
Status: Enrolling
Updated: 8/2/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Vitamin D in Vulnerable Adults (VIVA-VA)
Vitamin D in Vulnerable Adults
Status: Enrolling
Updated:  8/2/2013
mi
from
Miami, FL
Vitamin D in Vulnerable Adults (VIVA-VA)
Vitamin D in Vulnerable Adults
Status: Enrolling
Updated: 8/2/2013
VA Medical Center, Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Phoenix, AZ
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Carl T. Hayden VA Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Phoenix, AZ
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
HOPE Research Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Fresno, CA
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Dr. Jagpreet S. Mukker
mi
from
Fresno, CA
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Mather, CA
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
VA Northern California Health Care Sytem
mi
from
Mather, CA
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
New Haven, CT
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
North Amercian Center for Limb Preservation
mi
from
New Haven, CT
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Miami, FL
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
South Miami, FL
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Doctors Research Network
mi
from
South Miami, FL
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Tamarac, FL
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
South Florida Wound Care Group
mi
from
Tamarac, FL
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Saginaw, MI
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Covenant Wound Healing Center
mi
from
Saginaw, MI
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Las Vegas, NV
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Advanced Foot and Ankle Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Stony Brook, NY
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Erie, PA
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
Saint Vincent Health Center
mi
from
Erie, PA
Click here to add this to my saved trials
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated:  8/9/2013
mi
from
Tallin,
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
A Prospective, Multi-center, Longitudinal, Cohort Study of Dermagraft in Subjects With Venous Leg Ulcers: A Long-term Follow-up to the DEVO-Trial
Status: Enrolling
Updated: 8/9/2013
East-Tallinn Central Hospital Department of Rheumatology
mi
from
Tallin,
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated:  9/9/2013
mi
from
Phoenix, AZ
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated:  9/9/2013
mi
from
Fort Smith, AR
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated:  9/9/2013
mi
from
Santa Clara, CA
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated:  9/9/2013
mi
from
Aurora, CO
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated:  9/9/2013
mi
from
Decatur, GA
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated:  9/9/2013
mi
from
Park Ridge, IL
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated:  9/9/2013
mi
from
Baltimore, MD
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated:  9/9/2013
mi
from
Ashville, NC
A Study of RG1662 in Individuals With Down Syndrome
A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Investigate Safety and Tolerability of RG1662 in Individuals With Down Syndrome
Status: Enrolling
Updated: 9/9/2013
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated:  9/13/2013
mi
from
Atlantis, FL
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated: 9/13/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated:  9/13/2013
mi
from
Clifton, NJ
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated: 9/13/2013
Pfizer Investigational Site
mi
from
Clifton, NJ
Click here to add this to my saved trials
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated:  9/13/2013
mi
from
Burke, VA
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
Randomized, Double-blind, Placebo-Controlled Trial Assessing The Effects of an Oral Dietary Supplement Containing Marine and Plant Extracts on Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
Status: Enrolling
Updated: 9/13/2013
Pfizer Investigational Site
mi
from
Burke, VA
Click here to add this to my saved trials
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated:  9/25/2013
mi
from
San Francisco, CA
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
University of California, San Francisco Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated:  9/25/2013
mi
from
New Haven, CT
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated:  9/25/2013
mi
from
Indianapolis, IN
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Clinical Research Center, Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated:  9/25/2013
mi
from
Durham, NC
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Duke Clinical Research Unit
mi
from
Durham, NC
Click here to add this to my saved trials
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated:  9/25/2013
mi
from
Houston, TX
A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated:  9/25/2013
mi
from
San Francisco, CA
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
University of California - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated:  9/25/2013
mi
from
New Haven, CT
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated:  9/25/2013
mi
from
Indianapolis, IN
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Clinical Research Center, Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated:  9/25/2013
mi
from
Durham, NC
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
Duke Clinical Research Unit
mi
from
Durham, NC
Click here to add this to my saved trials
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated:  9/25/2013
mi
from
Houston, TX
An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
An Open-Label, Long-Term, Extension Study to Evaluate the Safety and Efficacy of KRN23 in Adult Subjects With X-Linked Hypophosphatemia
Status: Enrolling
Updated: 9/25/2013
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials